25 XP   0   0   10

Eurofins Scientific SE
Buy, Hold or Sell?

Let's analyse Eurofins together

PenkeI guess you are interested in Eurofins Scientific SE. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Eurofins Scientific SE. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Eurofins Scientific SE

I send you an email if I find something interesting about Eurofins Scientific SE.

Quick analysis of Eurofins (30 sec.)










What can you expect buying and holding a share of Eurofins? (30 sec.)

How much money do you get?

How much money do you get?
$4.13
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$20.91
Expected worth in 1 year
$7.03
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
$-9.75
Return On Investment
-15.0%

For what price can you sell your share?

Current Price per Share
$65.00
Expected price per share
$56.93 - $70.00
How sure are you?
50%

1. Valuation of Eurofins (5 min.)




Live pricePrice per Share (EOD)

$65.00

Intrinsic Value Per Share

$-17.11 - $38.58

Total Value Per Share

$3.80 - $59.49

2. Growth of Eurofins (5 min.)




Is Eurofins growing?

Current yearPrevious yearGrowGrow %
How rich?$4.1b$4.8b-$713.6m-17.2%

How much money is Eurofins making?

Current yearPrevious yearGrowGrow %
Making money$330.5m$650.2m-$319.6m-96.7%
Net Profit Margin4.8%9.1%--

How much money comes from the company's main activities?

3. Financial Health of Eurofins (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#13 / 145

Most Revenue
#4 / 145

Most Profit
#10 / 145

What can you expect buying and holding a share of Eurofins? (5 min.)

Welcome investor! Eurofins's management wants to use your money to grow the business. In return you get a share of Eurofins.

What can you expect buying and holding a share of Eurofins?

First you should know what it really means to hold a share of Eurofins. And how you can make/lose money.

Speculation

The Price per Share of Eurofins is $65.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Eurofins.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Eurofins, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $20.91. Based on the TTM, the Book Value Change Per Share is $-3.47 per quarter. Based on the YOY, the Book Value Change Per Share is $1.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $1.03 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Eurofins.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps1.672.6%1.672.6%3.114.8%2.463.8%1.582.4%
Usd Book Value Change Per Share-3.47-5.3%-3.47-5.3%1.061.6%1.362.1%1.892.9%
Usd Dividend Per Share1.031.6%1.031.6%1.031.6%0.610.9%0.380.6%
Usd Total Gains Per Share-2.44-3.7%-2.44-3.7%2.093.2%1.973.0%2.273.5%
Usd Price Per Share64.31-64.31-72.39-182.44-292.87-
Price to Earnings Ratio38.50-38.50-23.27-165.66-411.62-
Price-to-Total Gains Ratio-26.39--26.39-34.60-105.56-137.91-
Price to Book Ratio3.08-3.08-2.97-10.71-31.15-
Price-to-Total Gains Ratio-26.39--26.39-34.60-105.56-137.91-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share65
Number of shares15
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share1.030.61
Usd Book Value Change Per Share-3.471.36
Usd Total Gains Per Share-2.441.97
Gains per Quarter (15 shares)-36.5629.53
Gains per Year (15 shares)-146.22118.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
162-208-1563782108
2124-416-30273163226
3186-625-448110245344
4248-833-594146326462
5310-1041-740183408580
6372-1249-886219490698
7434-1458-1032256571816
8496-1666-1178292653934
9558-1874-13243297341052
10620-2082-14703658161170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%21.01.00.095.5%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%20.02.00.090.9%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.04.081.8%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%20.02.00.090.9%

Fundamentals of Eurofins

About Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Fundamental data was last updated by Penke on 2024-04-21 10:20:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Eurofins Scientific SE.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Eurofins earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Eurofins to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 4.8% means that $0.05 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Eurofins Scientific SE:

  • The MRQ is 4.8%. The company is making a profit. +1
  • The TTM is 4.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.8%TTM4.8%0.0%
TTM4.8%YOY9.1%-4.3%
TTM4.8%5Y7.9%-3.2%
5Y7.9%10Y7.0%+1.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8%-7.7%+12.5%
TTM4.8%-6.7%+11.5%
YOY9.1%2.4%+6.7%
5Y7.9%-1.5%+9.4%
10Y7.0%-3.4%+10.4%
1.1.2. Return on Assets

Shows how efficient Eurofins is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Eurofins to the Diagnostics & Research industry mean.
  • 3.0% Return on Assets means that Eurofins generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Eurofins Scientific SE:

  • The MRQ is 3.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.0%TTM3.0%0.0%
TTM3.0%YOY6.4%-3.4%
TTM3.0%5Y5.6%-2.5%
5Y5.6%10Y4.7%+0.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0%-1.7%+4.7%
TTM3.0%-1.3%+4.3%
YOY6.4%-0.9%+7.3%
5Y5.6%-0.5%+6.1%
10Y4.7%-0.9%+5.6%
1.1.3. Return on Equity

Shows how efficient Eurofins is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Eurofins to the Diagnostics & Research industry mean.
  • 8.1% Return on Equity means Eurofins generated $0.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Eurofins Scientific SE:

  • The MRQ is 8.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.1%TTM8.1%0.0%
TTM8.1%YOY13.6%-5.5%
TTM8.1%5Y12.5%-4.4%
5Y12.5%10Y11.5%+1.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ8.1%-0.7%+8.8%
TTM8.1%-0.1%+8.2%
YOY13.6%0.3%+13.3%
5Y12.5%-1.4%+13.9%
10Y11.5%-2.3%+13.8%

1.2. Operating Efficiency of Eurofins Scientific SE.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Eurofins is operating .

  • Measures how much profit Eurofins makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Eurofins to the Diagnostics & Research industry mean.
  • An Operating Margin of 8.4% means the company generated $0.08  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Eurofins Scientific SE:

  • The MRQ is 8.4%. The company is operating less efficient.
  • The TTM is 8.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ8.4%TTM8.4%0.0%
TTM8.4%YOY12.8%-4.4%
TTM8.4%5Y13.2%-4.8%
5Y13.2%10Y12.2%+1.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ8.4%-6.2%+14.6%
TTM8.4%0.5%+7.9%
YOY12.8%4.3%+8.5%
5Y13.2%3.7%+9.5%
10Y12.2%-1.3%+13.5%
1.2.2. Operating Ratio

Measures how efficient Eurofins is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.92 means that the operating costs are $0.92 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Eurofins Scientific SE:

  • The MRQ is 0.916. The company is less efficient in keeping operating costs low.
  • The TTM is 0.916. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.916TTM0.9160.000
TTM0.916YOY0.883+0.033
TTM0.9165Y0.878+0.038
5Y0.87810Y0.890-0.011
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9161.296-0.380
TTM0.9161.301-0.385
YOY0.8831.238-0.355
5Y0.8781.268-0.390
10Y0.8901.217-0.327

1.3. Liquidity of Eurofins Scientific SE.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Eurofins is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.45 means the company has $1.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Eurofins Scientific SE:

  • The MRQ is 1.445. The company is just able to pay all its short-term debts.
  • The TTM is 1.445. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.445TTM1.4450.000
TTM1.445YOY1.305+0.140
TTM1.4455Y1.300+0.145
5Y1.30010Y1.437-0.137
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4452.111-0.666
TTM1.4452.298-0.853
YOY1.3052.581-1.276
5Y1.3003.012-1.712
10Y1.4373.081-1.644
1.3.2. Quick Ratio

Measures if Eurofins is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Eurofins to the Diagnostics & Research industry mean.
  • A Quick Ratio of 1.56 means the company can pay off $1.56 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Eurofins Scientific SE:

  • The MRQ is 1.560. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.560. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.560TTM1.5600.000
TTM1.560YOY1.254+0.306
TTM1.5605Y1.251+0.309
5Y1.25110Y1.518-0.267
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5601.204+0.356
TTM1.5601.285+0.275
YOY1.2541.565-0.311
5Y1.2511.925-0.674
10Y1.5182.128-0.610

1.4. Solvency of Eurofins Scientific SE.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Eurofins assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Eurofins to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.62 means that Eurofins assets are financed with 62.0% credit (debt) and the remaining percentage (100% - 62.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Eurofins Scientific SE:

  • The MRQ is 0.620. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.620. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.620TTM0.6200.000
TTM0.620YOY0.519+0.101
TTM0.6205Y0.567+0.053
5Y0.56710Y0.596-0.029
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6200.421+0.199
TTM0.6200.407+0.213
YOY0.5190.394+0.125
5Y0.5670.448+0.119
10Y0.5960.446+0.150
1.4.2. Debt to Equity Ratio

Measures if Eurofins is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Eurofins to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 165.6% means that company has $1.66 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Eurofins Scientific SE:

  • The MRQ is 1.656. The company is just able to pay all its debts with equity.
  • The TTM is 1.656. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.656TTM1.6560.000
TTM1.656YOY1.094+0.562
TTM1.6565Y1.361+0.295
5Y1.36110Y1.589-0.228
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6560.606+1.050
TTM1.6560.567+1.089
YOY1.0940.631+0.463
5Y1.3610.658+0.703
10Y1.5890.742+0.847

2. Market Valuation of Eurofins Scientific SE

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Eurofins generates.

  • Above 15 is considered overpriced but always compare Eurofins to the Diagnostics & Research industry mean.
  • A PE ratio of 38.50 means the investor is paying $38.50 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Eurofins Scientific SE:

  • The EOD is 38.916. Based on the earnings, the company is overpriced. -1
  • The MRQ is 38.502. Based on the earnings, the company is overpriced. -1
  • The TTM is 38.502. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD38.916MRQ38.502+0.413
MRQ38.502TTM38.5020.000
TTM38.502YOY23.271+15.232
TTM38.5025Y165.662-127.159
5Y165.66210Y411.624-245.962
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD38.916-0.261+39.177
MRQ38.502-0.409+38.911
TTM38.502-0.341+38.843
YOY23.2710.002+23.269
5Y165.6624.832+160.830
10Y411.6245.198+406.426
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Eurofins Scientific SE:

  • The EOD is 30.392. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 30.069. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 30.069. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD30.392MRQ30.069+0.323
MRQ30.069TTM30.0690.000
TTM30.069YOY28.393+1.676
TTM30.0695Y101.120-71.051
5Y101.12010Y314.220-213.100
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD30.392-0.291+30.683
MRQ30.069-0.441+30.510
TTM30.069-1.388+31.457
YOY28.393-2.079+30.472
5Y101.120-1.446+102.566
10Y314.220-1.971+316.191
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Eurofins is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 3.08 means the investor is paying $3.08 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Eurofins Scientific SE:

  • The EOD is 3.109. Based on the equity, the company is fair priced.
  • The MRQ is 3.076. Based on the equity, the company is fair priced.
  • The TTM is 3.076. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.109MRQ3.076+0.033
MRQ3.076TTM3.0760.000
TTM3.076YOY2.969+0.107
TTM3.0765Y10.706-7.630
5Y10.70610Y31.148-20.442
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD3.1091.857+1.252
MRQ3.0762.228+0.848
TTM3.0762.222+0.854
YOY2.9693.104-0.135
5Y10.7063.447+7.259
10Y31.1484.036+27.112
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Eurofins Scientific SE compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---3.470-3.4700%1.061-427%1.360-355%1.886-284%
Book Value Per Share--20.90720.9070%24.377-14%20.517+2%14.770+42%
Current Ratio--1.4451.4450%1.305+11%1.300+11%1.437+1%
Debt To Asset Ratio--0.6200.6200%0.519+19%0.567+9%0.596+4%
Debt To Equity Ratio--1.6561.6560%1.094+51%1.361+22%1.589+4%
Dividend Per Share--1.0331.0330%1.031+0%0.609+70%0.381+171%
Eps--1.6701.6700%3.111-46%2.462-32%1.577+6%
Free Cash Flow Per Share--2.1392.1390%2.549-16%3.213-33%1.999+7%
Free Cash Flow To Equity Per Share--4.8084.8080%0.882+445%2.016+139%3.254+48%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--38.582--------
Intrinsic Value_10Y_min---17.109--------
Intrinsic Value_1Y_max--3.443--------
Intrinsic Value_1Y_min--1.074--------
Intrinsic Value_3Y_max--10.666--------
Intrinsic Value_3Y_min--0.830--------
Intrinsic Value_5Y_max--18.279--------
Intrinsic Value_5Y_min---2.037--------
Market Cap12543764480.000-1%12726949000.00012726949000.0000%14404615000.000-12%35599693914.240-64%56713885050.944-78%
Net Profit Margin--0.0480.0480%0.091-48%0.079-40%0.070-32%
Operating Margin--0.0840.0840%0.128-34%0.132-36%0.122-31%
Operating Ratio--0.9160.9160%0.883+4%0.878+4%0.890+3%
Pb Ratio3.109+1%3.0763.0760%2.969+4%10.706-71%31.148-90%
Pe Ratio38.916+1%38.50238.5020%23.271+65%165.662-77%411.624-91%
Price Per Share65.000+1%64.31064.3100%72.385-11%182.441-65%292.868-78%
Price To Free Cash Flow Ratio30.392+1%30.06930.0690%28.393+6%101.120-70%314.220-90%
Price To Total Gains Ratio-26.671-1%-26.388-26.3880%34.599-176%105.564-125%137.915-119%
Quick Ratio--1.5601.5600%1.254+24%1.251+25%1.518+3%
Return On Assets--0.0300.0300%0.064-53%0.056-45%0.047-35%
Return On Equity--0.0810.0810%0.136-40%0.125-35%0.115-29%
Total Gains Per Share---2.437-2.4370%2.092-216%1.969-224%2.267-208%
Usd Book Value--4137400000.0004137400000.0000%4851000000.000-15%4056000000.000+2%2898542100.000+43%
Usd Book Value Change Per Share---3.470-3.4700%1.061-427%1.360-355%1.886-284%
Usd Book Value Per Share--20.90720.9070%24.377-14%20.517+2%14.770+42%
Usd Dividend Per Share--1.0331.0330%1.031+0%0.609+70%0.381+171%
Usd Eps--1.6701.6700%3.111-46%2.462-32%1.577+6%
Usd Free Cash Flow--423256320.000423256320.0000%507332160.000-17%636035328.000-33%393746765.760+7%
Usd Free Cash Flow Per Share--2.1392.1390%2.549-16%3.213-33%1.999+7%
Usd Free Cash Flow To Equity Per Share--4.8084.8080%0.882+445%2.016+139%3.254+48%
Usd Market Cap12543764480.000-1%12726949000.00012726949000.0000%14404615000.000-12%35599693914.240-64%56713885050.944-78%
Usd Price Per Share65.000+1%64.31064.3100%72.385-11%182.441-65%292.868-78%
Usd Profit--330549120.000330549120.0000%650229120.000-49%519501312.000-36%342988081.920-4%
Usd Revenue--6941957760.0006941957760.0000%7152413760.000-3%6382091520.000+9%4538973709.440+53%
Usd Total Gains Per Share---2.437-2.4370%2.092-216%1.969-224%2.267-208%
 EOD+1 -7MRQTTM+0 -0YOY+7 -285Y+14 -2110Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of Eurofins Scientific SE based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1538.916
Price to Book Ratio (EOD)Between0-13.109
Net Profit Margin (MRQ)Greater than00.048
Operating Margin (MRQ)Greater than00.084
Quick Ratio (MRQ)Greater than11.560
Current Ratio (MRQ)Greater than11.445
Debt to Asset Ratio (MRQ)Less than10.620
Debt to Equity Ratio (MRQ)Less than11.656
Return on Equity (MRQ)Greater than0.150.081
Return on Assets (MRQ)Greater than0.050.030
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Eurofins Scientific SE based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.372
Ma 20Greater thanMa 5063.983
Ma 50Greater thanMa 10062.128
Ma 100Greater thanMa 20061.735
OpenGreater thanClose67.228
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Other Stockholders Equity  999,8002001,000,000-3,600996,400-427,900568,500-623,400-54,900



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets10,888,600
Total Liabilities6,751,200
Total Stockholder Equity4,077,500
 As reported
Total Liabilities 6,751,200
Total Stockholder Equity+ 4,077,500
Total Assets = 10,888,600

Assets

Total Assets10,888,600
Total Current Assets3,066,400
Long-term Assets7,822,200
Total Current Assets
Cash And Cash Equivalents 749,100
Short-term Investments 472,100
Net Receivables 1,617,000
Inventory 139,000
Other Current Assets 89,200
Total Current Assets  (as reported)3,066,400
Total Current Assets  (calculated)3,066,400
+/-0
Long-term Assets
Property Plant Equipment 2,297,400
Goodwill 4,551,400
Intangible Assets 796,000
Long-term Assets  (as reported)7,822,200
Long-term Assets  (calculated)7,644,800
+/- 177,400

Liabilities & Shareholders' Equity

Total Current Liabilities2,121,700
Long-term Liabilities4,629,500
Total Stockholder Equity4,077,500
Total Current Liabilities
Short-term Debt 601,100
Short Long Term Debt 458,300
Accounts payable 600,200
Other Current Liabilities 727,600
Total Current Liabilities  (as reported)2,121,700
Total Current Liabilities  (calculated)2,387,200
+/- 265,500
Long-term Liabilities
Long term Debt 2,889,400
Capital Lease Obligations 578,800
Long-term Liabilities Other 100
Long-term Liabilities  (as reported)4,629,500
Long-term Liabilities  (calculated)3,468,300
+/- 1,161,200
Total Stockholder Equity
Common Stock1,900
Retained Earnings 2,393,800
Accumulated Other Comprehensive Income 1,736,700
Other Stockholders Equity -54,900
Total Stockholder Equity (as reported)4,077,500
Total Stockholder Equity (calculated)4,077,500
+/-0
Other
Capital Stock1,900
Cash and Short Term Investments 1,221,200
Common Stock Shares Outstanding 197,900
Current Deferred Revenue192,800
Liabilities and Stockholders Equity 10,888,600
Net Debt 4,177,600
Net Invested Capital 8,425,200
Net Working Capital 944,700
Property Plant and Equipment Gross 4,919,100
Short Long Term Debt Total 4,926,700



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
> Total Assets 
160,263
166,481
190,125
266,162
460,338
612,025
734,010
659,299
736,161
1,074,575
1,159,096
1,497,016
1,873,190
3,699,833
4,129,415
5,832,307
7,205,448
7,823,100
8,575,500
9,332,300
10,083,500
10,888,600
10,888,60010,083,5009,332,3008,575,5007,823,1007,205,4485,832,3074,129,4153,699,8331,873,1901,497,0161,159,0961,074,575736,161659,299734,010612,025460,338266,162190,125166,481160,263
   > Total Current Assets 
65,168
65,541
83,351
115,891
199,165
232,555
311,982
231,651
295,829
441,886
433,246
644,542
621,072
1,424,307
1,579,413
1,826,578
1,705,402
1,604,100
2,518,200
2,319,000
2,313,300
3,066,400
3,066,4002,313,3002,319,0002,518,2001,604,1001,705,4021,826,5781,579,4131,424,307621,072644,542433,246441,886295,829231,651311,982232,555199,165115,89183,35165,54165,168
       Cash And Cash Equivalents 
-2,936
-3,777
36,195
41,240
80,350
64,770
131,666
54,360
107,504
179,490
134,281
297,257
216,620
793,755
826,098
820,357
506,246
297,000
912,400
515,300
486,600
749,100
749,100486,600515,300912,400297,000506,246820,357826,098793,755216,620297,257134,281179,490107,50454,360131,66664,77080,35041,24036,195-3,777-2,936
       Short-term Investments 
0
0
-351
0
-5,934
-6,673
0
0
0
0
0
181,624
73,825
591,101
506,019
153,293
24,599
3,600
8,700
17,400
54,400
472,100
472,10054,40017,4008,7003,60024,599153,293506,019591,10173,825181,62400000-6,673-5,9340-35100
       Net Receivables 
44,211
45,218
0
0
101,770
0
0
0
0
0
0
272,650
321,476
513,851
605,782
826,799
1,132,782
1,185,000
1,389,100
1,581,000
1,681,200
1,617,000
1,617,0001,681,2001,581,0001,389,1001,185,0001,132,782826,799605,782513,851321,476272,650000000101,7700045,21844,211
       Inventory 
6,976
6,997
7,108
9,430
17,046
24,762
7,649
7,769
8,389
9,949
13,864
20,141
24,623
37,515
39,547
51,805
66,373
79,300
157,000
154,200
145,600
139,000
139,000145,600154,200157,00079,30066,37351,80539,54737,51524,62320,14113,8649,9498,3897,7697,64924,76217,0469,4307,1086,9976,976
       Other Current Assets 
16,917
17,103
0
0
-1
0
0
0
0
0
0
58,929
61,676
48,510
55,432
148,738
1
63,200
83,200
68,500
-100
89,200
89,200-10068,50083,20063,2001148,73855,43248,51061,67658,929000000-10017,10316,917
   > Long-term Assets 
95,095
100,940
106,774
150,271
261,173
379,470
422,028
427,648
440,332
632,689
725,850
852,474
1,252,118
2,275,526
2,550,002
4,005,729
5,500,043
6,218,900
6,057,300
7,013,300
7,770,200
7,822,200
7,822,2007,770,2007,013,3006,057,3006,218,9005,500,0434,005,7292,550,0022,275,5261,252,118852,474725,850632,689440,332427,648422,028379,470261,173150,271106,774100,94095,095
       Property Plant Equipment 
35,804
39,590
41,192
46,589
71,376
106,938
128,989
135,002
137,085
163,186
209,304
251,113
323,747
427,541
506,818
685,998
1,018,005
1,593,500
1,574,900
1,829,900
2,167,700
2,297,400
2,297,4002,167,7001,829,9001,574,9001,593,5001,018,005685,998506,818427,541323,747251,113209,304163,186137,085135,002128,989106,93871,37646,58941,19239,59035,804
       Goodwill 
51,063
54,759
57,521
98,179
0
227,090
242,416
239,313
246,370
379,322
402,662
456,388
679,030
1,411,896
1,584,644
2,505,337
3,418,327
3,608,800
3,524,100
4,115,100
4,524,100
4,551,400
4,551,4004,524,1004,115,1003,524,1003,608,8003,418,3272,505,3371,584,6441,411,896679,030456,388402,662379,322246,370239,313242,416227,090098,17957,52154,75951,063
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
5,348
5,634
19,639
8,103
15,064
22,300
10,300
0
0
0
0
000010,30022,30015,0648,10319,6395,6345,34800000000000
       Intangible Assets 
0
0
2,309
-4,779
170,580
23,144
26,536
29,943
30,209
59,238
69,026
86,382
193,534
351,469
383,209
735,120
946,917
918,100
825,100
895,700
919,000
796,000
796,000919,000895,700825,100918,100946,917735,120383,209351,469193,53486,38269,02659,23830,20929,94326,53623,144170,580-4,7792,30900
       Long-term Assets Other 
2,307
2,273
1
7,509
3,723
2,388
7,976
7,747
9,390
11,483
20,197
186,059
80,010
592,701
506,019
153,293
50,330
54,500
56,600
81,700
100
796,000
796,00010081,70056,60054,50050,330153,293506,019592,70180,010186,05920,19711,4839,3907,7477,9762,3883,7237,50912,2732,307
> Total Liabilities 
107,352
112,628
124,027
183,746
357,700
396,461
514,892
456,265
505,470
754,260
782,974
1,102,276
1,208,949
2,619,522
2,372,701
3,350,334
4,483,266
4,925,000
4,859,100
4,655,200
5,232,500
6,751,200
6,751,2005,232,5004,655,2004,859,1004,925,0004,483,2663,350,3342,372,7012,619,5221,208,9491,102,276782,974754,260505,470456,265514,892396,461357,700183,746124,027112,628107,352
   > Total Current Liabilities 
54,156
57,452
60,334
90,002
128,535
180,877
189,535
177,834
208,621
266,491
316,982
338,713
451,505
774,969
710,009
1,451,893
1,450,660
1,581,600
1,696,400
1,855,700
1,772,200
2,121,700
2,121,7001,772,2001,855,7001,696,4001,581,6001,450,6601,451,893710,009774,969451,505338,713316,982266,491208,621177,834189,535180,877128,53590,00260,33457,45254,156
       Short-term Debt 
11,189
9,885
18,846
29,327
0
0
25,933
22,735
38,070
34,008
52,082
17,228
72,178
213,478
43,519
554,230
391,075
454,800
237,600
253,900
213,700
601,100
601,100213,700253,900237,600454,800391,075554,23043,519213,47872,17817,22852,08234,00838,07022,73525,9330029,32718,8469,88511,189
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
699,222
67,802
204,210
37,795
547,561
381,730
326,700
118,700
133,200
85,100
458,300
458,30085,100133,200118,700326,700381,730547,56137,795204,21067,802699,22200000000000
       Accounts payable 
15,775
14,041
16,059
23,676
44,101
73,241
65,274
51,917
61,062
82,833
77,798
100,951
127,141
197,015
230,122
301,863
373,010
409,800
542,000
627,600
647,700
600,200
600,200647,700627,600542,000409,800373,010301,863230,122197,015127,141100,95177,79882,83361,06251,91765,27473,24144,10123,67616,05914,04115,775
       Other Current Liabilities 
2,717
2,945
25,429
36,999
84,434
107,636
72,404
103,182
87,014
116,623
13,153
9,892
19,073
-1
43,511
1
1
62,200
780,100
-200
726,600
727,600
727,600726,600-200780,10062,2001143,511-119,0739,89213,153116,62387,014103,18272,404107,63684,43436,99925,4292,9452,717
   > Long-term Liabilities 
53,196
55,176
63,693
93,744
229,165
215,584
325,357
278,431
296,849
487,769
465,992
763,563
757,444
1,844,553
1,662,692
1,898,441
3,032,606
3,343,400
3,162,700
2,799,500
3,460,300
4,629,500
4,629,5003,460,3002,799,5003,162,7003,343,4003,032,6061,898,4411,662,6921,844,553757,444763,563465,992487,769296,849278,431325,357215,584229,16593,74463,69355,17653,196
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
81,569
107,028
341,100
320,674
236,103
266,300
256,500
245,500
299,100
348,500
0
0348,500299,100245,500256,500266,300236,103320,674341,100107,02881,56900000000000
> Total Stockholder Equity
52,875
53,509
65,852
79,574
98,910
203,600
212,586
196,624
224,999
315,456
374,604
387,686
656,483
957,340
1,627,477
2,443,170
2,669,190
2,838,600
3,690,300
4,647,600
4,782,100
4,077,500
4,077,5004,782,1004,647,6003,690,3002,838,6002,669,1902,443,1701,627,477957,340656,483387,686374,604315,456224,999196,624212,586203,60098,91079,57465,85253,50952,875
   Common Stock
1,321
1,324
1,363
1,375
1,388
1,398
1,416
1,421
1,429
1,435
1,488
1,507
1,520
1,539
1,693
1,764
1,775
1,800
1,900
1,900
1,900
1,900
1,9001,9001,9001,9001,8001,7751,7641,6931,5391,5201,5071,4881,4351,4291,4211,4161,3981,3881,3751,3631,3241,321
   Retained Earnings Total Equity0000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
197,014
738,503
918,525
1,008,355
1,118,100
1,377,900
1,684,900
1,878,700
1,736,700
1,736,7001,878,7001,684,9001,377,9001,118,1001,008,355918,525738,503197,0140000000000000
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
51,554
52,185
55,493
57,203
56,508
146,746
149,086
152,882
166,230
228,493
249,622
231,944
433,977
600,000
600,000
1,000,000
999,816
999,800
1,000,000
996,400
568,500
-54,900
-54,900568,500996,4001,000,000999,800999,8161,000,000600,000600,000433,977231,944249,622228,493166,230152,882149,086146,74656,50857,20355,49352,18551,554



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue6,514,600
Cost of Revenue-5,894,200
Gross Profit620,400620,400
 
Operating Income (+$)
Gross Profit620,400
Operating Expense-73,600
Operating Income546,800546,800
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense73,6000
 
Net Interest Income (+$)
Interest Income11,600
Interest Expense-118,700
Other Finance Cost-10,700
Net Interest Income-117,800
 
Pretax Income (+$)
Operating Income546,800
Net Interest Income-117,800
Other Non-Operating Income Expenses-
Income Before Tax (EBT)422,900670,700
EBIT - interestExpense = 428,100
425,700
428,900
Interest Expense118,700
Earnings Before Interest and Taxes (EBIT)546,800541,600
Earnings Before Interest and Taxes (EBITDA)1,211,100
 
After tax Income (+$)
Income Before Tax422,900
Tax Provision-115,500
Net Income From Continuing Ops307,800307,400
Net Income310,200
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses5,967,800
Total Other Income/Expenses Net-123,900117,800
 

Technical Analysis of Eurofins
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Eurofins. The general trend of Eurofins is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Eurofins's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Eurofins Scientific SE.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 67.95 < 70.00 < 70.00.

The bearish price targets are: 58.35 > 58.02 > 56.93.

Tweet this
Eurofins Scientific SE Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Eurofins Scientific SE. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Eurofins Scientific SE Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Eurofins Scientific SE. The current macd is 0.43186559.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Eurofins price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Eurofins. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Eurofins price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Eurofins Scientific SE Daily Moving Average Convergence/Divergence (MACD) ChartEurofins Scientific SE Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Eurofins Scientific SE. The current adx is 24.12.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Eurofins shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Eurofins Scientific SE Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Eurofins Scientific SE. The current sar is 61.25.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Eurofins Scientific SE Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Eurofins Scientific SE. The current rsi is 55.37. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Eurofins Scientific SE Daily Relative Strength Index (RSI) ChartEurofins Scientific SE Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Eurofins Scientific SE. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Eurofins price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Eurofins Scientific SE Daily Stochastic Oscillator ChartEurofins Scientific SE Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Eurofins Scientific SE. The current cci is 97.08.

Eurofins Scientific SE Daily Commodity Channel Index (CCI) ChartEurofins Scientific SE Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Eurofins Scientific SE. The current cmo is 13.65.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Eurofins Scientific SE Daily Chande Momentum Oscillator (CMO) ChartEurofins Scientific SE Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Eurofins Scientific SE. The current willr is -47.91666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Eurofins is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Eurofins Scientific SE Daily Williams %R ChartEurofins Scientific SE Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Eurofins Scientific SE.

Eurofins Scientific SE Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Eurofins Scientific SE. The current atr is 2.69581763.

Eurofins Scientific SE Daily Average True Range (ATR) ChartEurofins Scientific SE Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Eurofins Scientific SE. The current obv is -134,094.

Eurofins Scientific SE Daily On-Balance Volume (OBV) ChartEurofins Scientific SE Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Eurofins Scientific SE. The current mfi is 26.17.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Eurofins Scientific SE Daily Money Flow Index (MFI) ChartEurofins Scientific SE Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Eurofins Scientific SE.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Eurofins Scientific SE Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Eurofins Scientific SE based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.372
Ma 20Greater thanMa 5063.983
Ma 50Greater thanMa 10062.128
Ma 100Greater thanMa 20061.735
OpenGreater thanClose67.228
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Eurofins with someone you think should read this too:
  • Are you bullish or bearish on Eurofins? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Eurofins? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Eurofins Scientific SE

I send you an email if I find something interesting about Eurofins Scientific SE.


Comments

How you think about this?

Leave a comment

Stay informed about Eurofins Scientific SE.

Receive notifications about Eurofins Scientific SE in your mailbox!